Live News Categoriesmarket

VKTK (VKTK) News

Follow VKTK (VKTK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol VKTK Asset market Sector Markets 90 days 1 Updated Oct 14, 2026, 11:05 AM UTC Open live news feed

L Viking Therapeutics Starts Phase 3 Trial Program for Oral VK2735 in Obesity The company announced initiation of its oral VK2735 Phase 3 clinical program in patients with obesity. EQUITY | Oct 14, 2026, 11:05 AM UTC